QA: Progenics Pharmaceuticals INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000835887_2013_Progenics_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000835887, Progenics Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 67,467,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,399,000
3 remainder_Assets 5,442,000
4 LiabilitiesCurrent 8,662,000
5 LiabilitiesNoncurrent 1,078,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,706,000
9 ResearchAndDevelopmentExpense 31,840,000
10 remainder_Expenses 2,993,000
11 remainder_Revenues 14,048,000
12 remainder_NetIncome 60,000
13 remainder_ComprehensiveNetIncome 8,000
  yvar yval
0 Assets 76,308,000
1 Liabilities 9,740,000
2 Expenses 49,539,000
3 Revenues 14,048,000
4 StockholdersEquity 66,568,000
5 NetIncome -35,431,000
6 ComprehensiveNetIncome -35,427,000
7 BaseVar 74,851,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.55
9 EconomicCapitalRatio 3.39

Edgar->Model Mapping

Feature Distribution

Change over Time